Back to search

Oxular Limited

09331313

active
ltd
england wales
Companies House
Health Score
65 / 100

Some Concerns

25/30
Filing
0/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

The Charter Building, Vine Street, Uxbridge, UB8 1JG
Incorporated 27/11/2014

Previously known as

Precision Ocular Ltd · until 10/10/2016

Compliance

Last accounts

31/10/2024

total exemption full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 19/11/2025

Due 03/12/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mark Volpe

director · Since 20/12/2024

SENIOR VICE PRESIDENT

AMERICAN · UNITED STATES · Age 54

Also on 2 other boards

Zoran Berkovic

director · Since 20/12/2024

SENIOR VICE PRESIDENT

AMERICAN · UNITED STATES · Age 49

Also on 2 other boards

Zoran Berkovic

director · Since 20/12/2024

American · United States · Age 49

Mark Volpe

director · Since 20/12/2024

American · United States · Age 54

Former

John Edward Ilett

director · Resigned 28/02/2018

Nigel Aaron Pitchford

director · Resigned 28/02/2018

Bobby G. Soni

director · Resigned 22/03/2018

Ip Group Plc

corporate director · Resigned 27/03/2018

Paul Andrew Hayes

director · Resigned 04/02/2020

Carl Johan Spak

director · Resigned 08/04/2020

Ronald Yamamoto

director · Resigned 23/02/2021

Ronald Yamamoto

director · Resigned 27/01/2022

Dina Chaya Moghrabi

director · Resigned 31/01/2023

Thomas Cavanagh

director · Resigned 31/07/2023

David Fellows

director · Resigned 20/12/2024

Christina Takke

director · Resigned 20/12/2024

Ip2ipo Services Limited

corporate director · Resigned 20/12/2024

Rafiq Hasan

director · Resigned 20/12/2024

Dmitrij Hristodorov

director · Resigned 20/12/2024

Kenneth Macleod

director · Resigned 20/12/2024

Mark William-Semrau Gaffney

director · Resigned 20/12/2024

Persons with Significant Control

Regeneron Pharmaceuticals, Inc.

75–100% shares
75–100% votes
Appoint directors

777, Old Saw Mill River Road, Tarrytown, 10591

Reg: 1226128 · New York State Department Of State'S Division Of Corporations · New York Corporation

Notified 20/12/2024

Charges0 outstanding

Charge
satisfied

HSBC UK BANK PLC

Created 21/02/2022Registered 22/02/2022Satisfied 03/09/2024

Change History

statusactive
2026-07-17

Active

typeltd
2026-07-17

Private Limited Company

address line1The Charter Building
2026-07-17

THE CHARTER BUILDING

post townUxbridge
2026-07-17

UXBRIDGE

CompanyRankvs 597+ SIC 72110 peers
61

Financial strength85th percentile among SIC peers · 21/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 3.05× · 20/20
Longevity12 years trading (max 15) · 12/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength21/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity12/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

in accordance with IFRS as adopted by the UK , subject to any material departures disclosed and explained in the financial statements; ∙ assess the Group and Company 's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and ∙ use the going concern basis of accounting unless they either intend to liquidate the Group or the Company or to cease

Key FinancialsYear ending 31/10/2023

Net Worth

£230k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

Working capital

Current Assets

£11.8M

Current Liabilities

£3.9M

Profit After Tax

-£11.8M

0avg. employees

Balance Sheet

Total assets£12.1M
Prepared with Caseware UK (AP4) 2022.0.179

EstimatesDerived

YearCurrent Ratio
20233.05

Derived from filed accounts. Not audited figures.